Skip to main content

Centene (CNC) Receives a Buy from Bernstein

Tipranks - Tipranks - Wed Jan 28, 6:56AM CST

Bernstein analyst Lance Wilkes maintained a Buy rating on Centene today and set a price target of $59.00.

Claim 50% Off TipRanks Premium

According to TipRanks, Wilkes is a 2-star analyst with an average return of 0.8% and a 50.00% success rate. Wilkes covers the Healthcare sector, focusing on stocks such as CVS Health, Agilon Health, and Centene.

The word on The Street in general, suggests a Hold analyst consensus rating for Centene with a $43.46 average price target.

See the top stocks recommended by analysts >>

Based on Centene’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $49.69 billion and a GAAP net loss of $6.63 billion. In comparison, last year the company earned a revenue of $42.02 billion and had a net profit of $713 million

Based on the recent corporate insider activity of 57 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of CNC in relation to earlier this year. Last month, Kenneth Burdick, a Director at CNC sold 66,007.00 shares for a total of $2,575,601.44.

Read More on CNC:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).